MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-OD-19-0050644
Seranti Pharmaceuticals Private Limited
Seranti Pharmaceuticals Private Limited - healthcare in Secunderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹91.88 Lakh
▼ 16% YoY
Net profit · FY 2025
₹89,274
Net margin 1%
EBITDA · FY 2025
₹5.65 Lakh
EBITDA margin 6.2%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹21.62 Lakh
Issued & subscribed
Open charges
₹47.2 Lakh
Satisfied ₹18.5 Lakh
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
About Seranti Pharmaceuticals Private Limited
Data last updated:
Seranti Pharmaceuticals Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 04 November 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2010PTC071088. Its GSTIN is 21AAOCS9748Q2ZB (Odisha). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹21.62 Lakh. It is led by directors Ahuti Rautaray (Managing Director) and Susanta Senapati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3 – 3 – 66/Fc Surya Selter – I Infront Of Bolaram Stati Risala Bazar Burtonguda, Secunderabad, Telangana, India – 500010.
As per the financials filed for FY 2025, the company reported a revenue of ₹91.88 Lakh, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹89,274 (net margin 1%) and EBITDA of ₹5.65 Lakh (EBITDA margin 6.2%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹47.2 Lakh and satisfied charges of ₹18.5 Lakh on record.
Seranti Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-19-0050644). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233TG2010PTC071088
Registration Number 071088
Incorporation Date 04 November 2010
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-OD-19-0050644
CIN history
Seranti Pharmaceuticals has one previous CIN (Corporate Identification Number): U24233AP2010PTC071088. The current CIN is U24233TG2010PTC071088, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2010PTC071088 | Current |
| U24233AP2010PTC071088 | Previous |
Recognitions & Rankings of Seranti Pharmaceuticals
Contact details
Seranti Pharmaceuticals Private Limited's registered office is in Secunderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address3 – 3 – 66/Fc Surya Selter – I Infront Of Bolaram Stati Risala Bazar Burtonguda, Secunderabad, Telangana, India – 500010
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Seranti Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Seranti Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Seranti Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Seranti Pharmaceuticals Private Limited, buy the company report.
Financials of Seranti Pharmaceuticals Private Limited
FY 2025 filings availableSeranti Pharmaceuticals Private Limited reported revenue of ₹91.88 Lakh (down 16% YoY) for FY 2025.
Revenue · FY 2025
₹91.88 Lakh ▼ 16%
Net profit · FY 2025
₹89,274 margin 1%
EBITDA · FY 2025
₹5.65 Lakh margin 6.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 16%
3 years · compounded
▲ 6%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 10%
5 years · compounded
▲ 5%
Revenue fell 16% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹89,274 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Seranti Pharmaceuticals Private Limited, buy the company report.
Board of directors of Seranti Pharmaceuticals Private Limited
Seranti Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ahuti Rautaray | Managing Director | 04 Nov 2010 | 16 Years 0 Months | Current |
| Susanta Senapati | Director | 14 Dec 2020 | 5 Years 10 Months | Current |
Auditor
Seranti Pharmaceuticals Private Limited is audited by SPP ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SPP ASSOCIATES | FY 2023 | 322862E |
Shareholding
The shareholding of Seranti Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Seranti Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹47.2 Lakh
Satisfied charges
₹18.5 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Apr 2022 | 100569552 | Others | ₹2.4 Lakh | Open | |
| 30 Apr 2022 | 100569553 | Others | ₹4.8 Lakh | Open | |
| 31 May 2016 | 100038369 | Others | ₹40 Lakh | Open | |
| 20 Aug 2014 | 10525064 | Syndicate Bank | ₹13.5 Lakh | Satisfied | |
| 05 Dec 2013 | 10469356 | Oriental Bank of Commerce | ₹5 Lakh | Satisfied |
To see the full charge records of Seranti Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Seranti Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Seranti Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Seranti Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 10, 2024.
Active EPFO establishments
1
GST
Seranti Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAOCS9748Q2ZB | Odisha | Active | 20 Mar 2018 |
To see the full GST registrations and return filing status of Seranti Pharmaceuticals Private Limited, buy the company report.
Recent activity
Seranti Pharmaceuticals Private Limited has 3 board changes on record since 2010: 2 appointments and 1 cessation. The latest: Minati Senapati ceased to be Director on 14 Dec 2020.
AGM
Seranti Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Seranti Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others of Rs. 40.00 Lakh registered on 31 May 2016 with Charge ID 100038369 was modified on 24 Jun 2023.
Charges
A charge with Others amounted to Rs. 2.40 Lakh with Charge ID 100569552 was registered on 30 Apr 2022.
Charges
A charge with Others amounted to Rs. 4.80 Lakh with Charge ID 100569553 was registered on 30 Apr 2022.
Ceased
Minati Senapati ceased to be Director.
Appointed
Susanta Senapati was appointed as Director.
Charges
A charge registered on 20 Aug 2014 via Charge ID 10525064 with Syndicate Bank was fully satisfied on 02 Jul 2016.
Charges
A charge with Others amounted to Rs. 40.00 Lakh with Charge ID 100038369 was registered on 31 May 2016.
Charges
A charge registered on 05 Dec 2013 via Charge ID 10469356 with Oriental Bank Of Commerce was fully satisfied on 18 May 2016.
Charges
A charge with Syndicate Bank of Rs. 13.50 Lakh registered on 20 Aug 2014 with Charge ID 10525064 was modified on 07 Nov 2015.
Charges
A charge with Syndicate Bank amounted to Rs. 13.50 Lakh with Charge ID 10525064 was registered on 20 Aug 2014.
3 earlier events are in the company report.
Frequently asked questions
Seranti Pharmaceuticals is an active private limited company based in Secunderabad, Telangana, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 04 November 2010 (16+ years old) and is registered under CIN U24233TG2010PTC071088.
Seranti Pharmaceuticals has 2 current directors:
- Ahuti Rautaray - Managing Director
- Susanta Senapati - Director
The latest financial statements of Seranti Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Seranti Pharmaceuticals is 21AAOCS9748Q2ZB, registered in Odisha. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Seranti Pharmaceuticals is U24233TG2010PTC071088. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Seranti Pharmaceuticals was incorporated on 04 November 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.
Minati Senapati ceased to be Director on 14 Dec 2020. Susanta Senapati was appointed as Director on 14 Dec 2020. Ahuti Rautaray was appointed as Managing Director on 04 Nov 2010.
Yes, Seranti Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-19-0050644).
The registered office of Seranti Pharmaceuticals is at 3 – 3 – 66Fc Surya Selter – I Infront Of Bolaram Stati Risala Bazar Burtonguda, Secunderabad, Telangana, India – 500010.
Seranti Pharmaceuticals operates in the healthcare industry, in the preventive health services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages